In vitro and in vivo studies revealed that the knockdown of NKG2A in NK cells using shRNA or siRNA instigates “missing-self” responses and promotes the anti-tumor activity against HLA-E expressing cancer cell lines [120,121]. The gene discussed is HLA-E; the disease is cancer.